Cargando…

Invariant NKT cells are resistant to circulating CD15(+) myeloid‐derived suppressor cells in patients with head and neck cancer

Myeloid‐derived suppressor cells (MDSC) are a heterogeneous population of immature and progenitor myeloid cells with an immunosuppressive role in various types of cancer, including head and neck squamous cell carcinoma (HNSCC). However, the effect on the host immune system, especially on invariant N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Horinaka, Atsushi, Sakurai, Daiju, Ihara, Fumie, Makita, Yuji, Kunii, Naoki, Motohashi, Shinichiro, Nakayama, Toshinori, Okamoto, Yoshitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2016
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4814259/ https://www.ncbi.nlm.nih.gov/pubmed/26679292 http://dx.doi.org/10.1111/cas.12866

Ejemplares similares

Activated iNKT cells enhance the anti-tumor effect of antigen specific CD8 T cells on mesothelin-expressing salivary gland cancer
por: Makita, Yuji, et al.
Publicado: (2018)

Blockade of programmed death-1/programmed death ligand pathway enhances the antitumor immunity of human invariant natural killer T cells
por: Kamata, Toshiko, et al.
Publicado: (2016)

NKT Cells as an Ideal Anti-Tumor Immunotherapeutic
por: Fujii, Shin-ichiro, et al.
Publicado: (2013)

Immunosuppressive property of submandibular lymph nodes in patients with head and neck tumors: differential distribution of regulatory T cells
por: Sakurai, Daiju, et al.
Publicado: (2018)

Clinical Application of iNKT Cell-mediated Anti-tumor Activity Against Lung Cancer and Head and Neck Cancer
por: Takami, Mariko, et al.
Publicado: (2018)

Regeneration of invariant natural killer T (iNKT) cells: application of iPSC technology for iNKT cell-targeted tumor immunotherapy
por: Aoki, Takahiro, et al.
Publicado: (2023)

CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy
por: Hara, Ayaka, et al.
Publicado: (2020)

Invariant NKT cells metabolically adapt to the acute myeloid leukaemia environment
por: Stavrou, Victoria, et al.
Publicado: (2022)

Intracellular Bacterial Infection and Invariant NKT Cells
por: Emoto, Masashi, et al.
Publicado: (2009)

Expansion of Lung Vα14 NKT Cells by Administration of α‐Galactosylceramide‐pulsed Dendritic Cells
por: Akutsu, Yasunori, et al.
Publicado: (2002)

Invariant NKT cells: Killers and conspirators against cancer
por: Bassiri, Hamid, et al.
Publicado: (2013)

Improved Detection of Cytokines Produced by Invariant NKT Cells
por: Sag, Duygu, et al.
Publicado: (2017)

Activation of Invariant NKT Cells Exacerbates Experimental Visceral Leishmaniasis
por: Stanley, Amanda C., et al.
Publicado: (2008)

Invariant NKT Cells: Regulation and Function during Viral Infection
por: Juno, Jennifer A., et al.
Publicado: (2012)

Invariant NKT Cell Response to Dengue Virus Infection in Human
por: Matangkasombut, Ponpan, et al.
Publicado: (2014)

Invariant NKT Cells as Novel Targets for Immunotherapy in Solid Tumors
por: Pilones, Karsten A., et al.
Publicado: (2012)

Effects of Invariant NKT Cells on Parasite Infections and Hygiene Hypothesis
por: Yang, Jun-Qi, et al.
Publicado: (2016)

Novel Approaches to Exploiting Invariant NKT Cells in Cancer Immunotherapy
por: Wolf, Benjamin J., et al.
Publicado: (2018)

Exploiting invariant NKT cells to promote T-cell responses to cancer vaccines
por: Hunn, Martin K., et al.
Publicado: (2013)

CD69 prevents PLZF(hi) innate precursors from prematurely exiting the thymus and aborting NKT2 cell differentiation
por: Kimura, Motoko Y., et al.
Publicado: (2018)

Vaccine Designs Utilizing Invariant NKT-Licensed Antigen-Presenting Cells Provide NKT or T Cell Help for B Cell Responses
por: Fujii, Shin-ichiro, et al.
Publicado: (2018)

Invariant NKT Cells as Initiators, Licensors, and Facilitators of the Adaptive Immune Response
por: Stein-Streilein, Joan
Publicado: (2003)

Invariant NKT cells are required for airway inflammation induced by environmental antigens
por: Wingender, Gerhard, et al.
Publicado: (2011)

Eomes transcription factor is required for the development and differentiation of invariant NKT cells
por: Shimizu, Kanako, et al.
Publicado: (2019)

TIM-4 is expressed on invariant NKT cells but dispensable for their development and function
por: Zhang, Xilin, et al.
Publicado: (2016)

Invariant NKT Cells and Rheumatic Disease: Focus on Primary Sjogren Syndrome
por: Rizzo, Chiara, et al.
Publicado: (2019)

Immune cells and preterm labour: do invariant NKT cells hold the key?
por: Rinaldi, S.F., et al.
Publicado: (2015)

Mouse Invariant Monoclonal Antibody NKT14: A Novel Tool to Manipulate iNKT Cell Function In Vivo
por: Scheuplein, Felix, et al.
Publicado: (2015)

Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer
por: Toyoda, Takahide, et al.
Publicado: (2020)

Critical Role of Myeloid-Derived Suppressor Cells in Tumor-Induced Liver Immune Suppression through Inhibition of NKT Cell Function
por: Zhang, Hongru, et al.
Publicado: (2017)

Invariant NKT cells recognize glycolipids from pathogenic Gram-positive bacteria
por: Kinjo, Yuki, et al.
Publicado: (2011)

Increased Intraepithelial Vα24 Invariant NKT Cells in the Celiac Duodenum
por: Montalvillo, Enrique, et al.
Publicado: (2015)

CD1d Expression and Invariant NKT Cell Responses in Herpesvirus Infections
por: Chung, Brian K., et al.
Publicado: (2015)

Harnessing Invariant NKT Cells to Improve Influenza Vaccines: A Pig Perspective
por: Yang, Guan, et al.
Publicado: (2017)

SOX4 controls invariant NKT cell differentiation by tuning TCR signaling
por: Malhotra, Nidhi, et al.
Publicado: (2018)

Leishmania infantum Exoproducts Inhibit Human Invariant NKT Cell Expansion and Activation
por: Belo, Renata, et al.
Publicado: (2017)

Primary Mouse Invariant Natural Killer T (iNKT) Cell Purification and Transduction
por: Delfanti, Gloria, et al.
Publicado: (2023)

Mouse CD8(+)NKT-like cells exert dual cytotoxicity against mouse tumor cells and myeloid-derived suppressor cells
por: Li, Zhengyuan, et al.
Publicado: (2019)

Activated invariant natural killer T cells directly recognize leukemia cells in a CD1d‐independent manner
por: Aoki, Takahiro, et al.
Publicado: (2020)

Soluble factors derived from neuroblastoma cell lines suppress dendritic cell differentiation and activation
por: Harada, Kazuaki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p3rl17so58albflvefkva6b3qa